Literature DB >> 23197293

Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models.

P Vandenabeele, S Grootjans, N Callewaert, N Takahashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23197293      PMCID： PMC3554339          DOI： 10.1038/cdd.2012.151

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN： 1350-9047            Impact factor:   15.828


× No keyword cloud information.
  18 in total

1.  Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis.

Authors:  George Trichonas; Yusuke Murakami; Aristomenis Thanos; Yuki Morizane; Maki Kayama; Christine M Debouck; Toshio Hisatomi; Joan W Miller; Demetrios G Vavvas
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

Authors:  Alexander J Muller; James B DuHadaway; P Scott Donover; Erika Sutanto-Ward; George C Prendergast
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

3.  Activity and specificity of necrostatin-1, small-molecule inhibitor of RIP1 kinase.

Authors:  A Degterev; J L Maki; J Yuan
Journal:  Cell Death Differ       Date:  2012-11-30       Impact factor: 15.828

4.  The dual functions of receptor interacting protein 1 in fas-induced hepatocyte death during sepsis.

Authors:  Sam I McNeal; Mark P LeGolvan; Chun-Shiang Chung; Alfred Ayala
Journal:  Shock       Date:  2011-05       Impact factor: 3.454

Review 5.  Towards a genetic definition of cancer-associated inflammation: role of the IDO pathway.

Authors:  George C Prendergast; Richard Metz; Alexander J Muller
Journal:  Am J Pathol       Date:  2010-03-12       Impact factor: 4.307

6.  Identification of RIP1 kinase as a specific cellular target of necrostatins.

Authors:  Alexei Degterev; Junichi Hitomi; Megan Germscheid; Irene L Ch'en; Olga Korkina; Xin Teng; Derek Abbott; Gregory D Cuny; Chengye Yuan; Gerhard Wagner; Stephen M Hedrick; Scott A Gerber; Alexey Lugovskoy; Junying Yuan
Journal:  Nat Chem Biol       Date:  2008-05       Impact factor: 15.040

7.  Necrostatin: a potentially novel cardioprotective agent?

Authors:  Christopher C T Smith; Sean M Davidson; Shiang Y Lim; James C Simpkin; John S Hothersall; Derek M Yellon
Journal:  Cardiovasc Drugs Ther       Date:  2007-07-31       Impact factor: 3.727

8.  Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis.

Authors:  Andrew Oberst; Christopher P Dillon; Ricardo Weinlich; Laura L McCormick; Patrick Fitzgerald; Cristina Pop; Razq Hakem; Guy S Salvesen; Douglas R Green
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

9.  RIP3 mediates the embryonic lethality of caspase-8-deficient mice.

Authors:  William J Kaiser; Jason W Upton; Alyssa B Long; Devon Livingston-Rosanoff; Lisa P Daley-Bauer; Razqallah Hakem; Tamara Caspary; Edward S Mocarski
Journal:  Nature       Date:  2011-03-02       Impact factor: 49.962

10.  Caspase-8 deficiency in epidermal keratinocytes triggers an inflammatory skin disease.

Authors:  Andrew Kovalenko; Jin-Chul Kim; Tae-Bong Kang; Akhil Rajput; Konstantin Bogdanov; Oliver Dittrich-Breiholz; Michael Kracht; Ori Brenner; David Wallach
Journal:  J Exp Med       Date:  2009-08-31       Impact factor: 14.307
View more
  69 in total

Review 1.  Pathophysiology of glia in perinatal white matter injury.

Authors:  Stephen A Back; Paul A Rosenberg
Journal:  Glia       Date:  2014-03-31       Impact factor: 7.452

2.  Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury.

Authors:  Andreas Linkermann; Jan Hinrich Bräsen; Maurice Darding; Mi Kyung Jin; Ana B Sanz; Jan-Ole Heller; Federica De Zen; Ricardo Weinlich; Alberto Ortiz; Henning Walczak; Joel M Weinberg; Douglas R Green; Ulrich Kunzendorf; Stefan Krautwald
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

3.  Inhibition of programmed necrosis limits infarct size through altered mitochondrial and immune responses in the aged female rat heart.

Authors:  Alexandra M Garvin; Morgan A Jackson; Donna H Korzick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-29       Impact factor: 4.733

4.  An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity.

Authors:  Olga Danilchanka; Jim Sun; Mikhail Pavlenok; Christian Maueröder; Alexander Speer; Axel Siroy; Joeli Marrero; Carolina Trujillo; David L Mayhew; Kathryn S Doornbos; Luis E Muñoz; Martin Herrmann; Sabine Ehrt; Christian Berens; Michael Niederweis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

5.  A20 is a regulator of necroptosis.

Authors:  Prajwal Gurung; Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

Review 6.  Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death.

Authors:  James M Murphy; John Silke
Journal:  EMBO Rep       Date:  2014-01-27       Impact factor: 8.807

7.  Knocking 'em Dead: Pore-Forming Proteins in Immune Defense.

Authors:  Xing Liu; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2020-01-31       Impact factor: 28.527

Review 8.  CYLD-mediated signaling and diseases.

Authors:  Bryan J Mathis; Yimu Lai; Chen Qu; Joseph S Janicki; Taixing Cui
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 9.  Programmed necrosis in the cross talk of cell death and inflammation.

Authors:  Francis Ka-Ming Chan; Nivea Farias Luz; Kenta Moriwaki
Journal:  Annu Rev Immunol       Date:  2014-12-10       Impact factor: 28.527

10.  Evaluation of RIP1K and RIP3K expressions in the malignant and benign breast tumors.

Authors:  Fatemeh Karami-Tehrani; Amin Rahimi Malek; Zahra Shahsavari; Morteza Atri
Journal:  Tumour Biol       Date:  2016-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.